Liver Transplantation Market By Treatment 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Liver Transplantation Market
Liver Transplantation Market: By Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment), By End-User (Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers) & By Region-Forecast (2016-2021)
Report Code : HCR 0315
Updated Date: 25 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Liver Transplantation Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Liver Transplantation Market– Market Forces
   4.1. Drivers
      4.1.1. Growing prevalence of Hepatitis A, B and C
   4.2. Restraints
      4.2.1. Inadequate number of donors
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Liver Transplantation Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Liver Transplantation Market, By Treatment
   6.1. Liver Transplantation Surgery
   6.2. Surgery Anti-Rejection Treatment
      6.2.1. Cyclosporine
      6.2.2. Tacrolimus
      6.2.3. Sirolimus
      6.2.4. Prednisone
      6.2.5. Azathioprine
      6.2.6. Mycophenolate Mofetil
7. Liver Transplantation Market, By End-User
   7.1. Hospitals
   7.2. Adult Liver Transplantation Centers
   7.3. Ambulatory Surgical Centers
8. Liver Transplantation Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Liver Transplantation – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Allosource
   10.2. Conatus Pharmaceuticals Inc.
   10.3. Digna Biotech
   10.4.  S.L.
   10.5. Dompe Farmaceutici S.p.A.
   10.6. Isogenis, Inc.
   10.7. RedHill Biopharma Ltd.
   10.8. Thompson Surgical
   10.9. Integra Life sciences
   10.10. Dompe Farmaceutici S.p.A
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Liver transplantation or hepatic transplantation is a medical surgical procedure performed on a patient suffering from the liver failure and is unable to to perform its normal functions such as synthesis of carbohydrates, proteins and fats. Liver failure is majorly caused by several disease conditions like liver cirrhosis, cystic fibrosis, hemochromatosis, primary biliary cirrhosis, primary sclerosing cholangitis and wilson’s disease. Liver transplantation is second most commonly transplantation surgery performed after the kidney, making it clear that liver disease is a common and serious problem. Majority of liver transplant operations use livers from deceased donors, though a liver may also come from another living person (allograft). Globally increasing awareness and spending on healthcare is expected to drive the demand for liver transplantation during the period of study.

 Liver Transplantation Market

Geographically North America dominated liver transplantation market driven by best in the class healthcare infrastructure, advanced facilities and awareness and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market  for liver transplantation surgery market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population and growing medical tourism industry in developing nations such as China and India in this region.

This report identifies the global liver transplantation market size in for the year 2014-2016 and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges and other key aspects with respect to global liver transplantation market.

This report segments liver transplantation market on the basis of treatment, end-user  and regional market as follows:
  • Liver Transplantation Market, By Treatment: Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment(Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil)
  • Liver Transplantation Market, By End-Usert: Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the liver transplantation market. Some of the major companies’ profiles in detail are as follows:
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech.
  • Dompe Farmaceutici S.p.A.
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports